Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cardiology

• Publication date

  2007-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJCARD.2007.08.001PMID 17804098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International variations in the treatment and co‐morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey

  2007cited by this paper
• [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].

  2007cited by this paper
• Heart failure clinic in a community hospital improves outcome in heart failure patients.

  2006cited by this paper
• Programme to improve the use of beta‐blockers for heart failure in the elderly and in those with severe symptoms: Results of the BRING‐UP 2 Study

  2006cited by this paper
• Heart Failure Management Programmes in Europe

  2006cited by this paper
• The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.

  2006cited by this paper
• Tolerability of beta‐blockers in elderly patients with chronic heart failure: The COLA II study

  2006cited by this paper
• Success of a multidisciplinary heart failure clinic for initiation and up‐titration of key therapeutic agents

  2005influential reference
• Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.

  2005cited by this paper
• Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.

  2005cited by this paper
• Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.

  2005cited by this paper
• Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

  2005cited by this paper
• Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey

  2005cited by this paper
• The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)

  2004cited by this paper
• Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.

  2004cited by this paper
• Adverse effects of -blocker therapy for patients with heart failure: A quantitative overview of ran

  2004cited by this paper
• Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.

  2004cited by this paper
• Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth.

  2003cited by this paper
• Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

  2003cited by this paper
• Improving Guideline Adherence: A Randomized Trial Evaluating Strategies to Increase &bgr;-Blocker Use in Heart Failure

  2003cited by this paper
• The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.

  2003cited by this paper
• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

  2003cited by this paper
• Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study.

  2003influential reference
• The management of patients with heart failure in a Slovenian community hospital: What has changed between 1997 and 2000?

  2003cited by this paper
• The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

  2003cited by this paper
• The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

  2003cited by this paper
• Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

  2002cited by this paper
• [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].

  2001cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• Effect of carvedilol on survival in severe chronic heart failure.

  2001cited by this paper
• Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure

  2001cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

  1996cited by this paper

• Rørth, R. et al. (2018) Evidence based therapy and its association with workforce detachment following first hospitalization for heart

  2018cites this paper
• Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure.

  2018cites this paper
• Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic

  2018cites this paper
• THE INFLUENCE OF SERTRALINE ON THE PHARMACOKINETICS OF CARVEDILOL . A PRECLINICAL STUDY ON RATS

  2017cites this paper
• Expert Comment: Is Medication Titration in Heart Failure too Complex?

  2017cites this paper
• The Pharmacokinetic Interaction Study between Carvedilol and Bupropion in Rats

  2017cites this paper
• Carvedilol versus non‐selective beta‐blockers for portal hypertension in cirrhosis

  2015cites this paper
• Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

  2014cites this paper
• Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease

  2014cites this paper
• Medical Management of Fatigue

  2013cites this paper
• Discontinuation of beta-blockers in cardiovascular disease: UK primary care cohort study.

  2013cites this paper
• Effects of age on aerobic capacity in heart failure patients under beta-blocker therapy: possible impact in clinical decision-making?

  2013cites this paper
• Clinical status and outcome of Japanese heart failure patients with reduced or preserved ejection fraction treated with carvedilol.

  2013cites this paper
• Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis.

  2013cites this paper
• Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?

  2012influential citation
• Aerobic exercise prescription in patients with chronic heart failure: a review in the beta-blocker era

  2012cites this paper
• Use of carvedilol in hypertension: an update

  2012cites this paper
• Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.

  2012cites this paper
• Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.

  2011cites this paper
• Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.

  2011cites this paper
• Heart failure treatment in the elderly

  2011cites this paper
• Behandeling van chronisch hartfalen

  2011cites this paper
• The carvedilol's beta-blockade in heart failure and exercise training's sympathetic blockade in healthy athletes during the rest and peak effort.

  2010cites this paper
• Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE‐HF, COACH galectin‐3 substudy, HF‐ACTION nuclear substudy, DAD‐HF, and MARVEL‐1

  2010cites this paper
• The Gap Between Clinical Trials and Clinical Practice: The Use of Pragmatic Clinical Trials to Inform Regulatory Decision Making

  2010cites this paper
• Behandeling van chronisch hartfalen

  2010cites this paper
• Clinical updates on carvedilol: a first choice β-blocker in the treatment of cardiovascular diseases

  2010cites this paper
• Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy: heart rate dynamic during exercise test.

  2010cites this paper
• Norepinephrine Remains Increased in the Six-Minute Walking Test after Heart Transplantation

  2010cites this paper
• Current treatment of chronic heart failure in primary care; still room for improvement.

  2010cites this paper
• Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review

  2009cites this paper
• Beta-blocker tolerability in elderly heart failure patients.

  2009cites this paper
• Nitric oxide mechanisms of nebivolol

  2009cites this paper
• From surveys to trials in the beta blocker world

  2009cites this paper
• Role of carvedilol controlled-release in cardiovascular disease

  2009cites this paper
• The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure

  2009cites this paper
• Beta-blockers in elderly patients with heart failure ready for prime time?

  2009cites this paper
• The top papers by download and citations from the International Journal of Cardiology in 2007.

  2008cites this paper
• Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial

  2008cites this paper
• Challenges of Beta Blocker Therapy in Chronic Heart Failure: The Story Continues

  2008cites this paper